These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 8420218)
1. Fifteen months' follow-up on bilateral embryonic mesencephalic grafts in two cases of severe MPTP-induced parkinsonism. Widner H; Tetrud J; Rehncrona S; Snow BJ; Brundin P; Björklund A; Lindvall O; Langston JW Adv Neurol; 1993; 60():729-33. PubMed ID: 8420218 [No Abstract] [Full Text] [Related]
2. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Widner H; Tetrud J; Rehncrona S; Snow B; Brundin P; Gustavii B; Björklund A; Lindvall O; Langston JW N Engl J Med; 1992 Nov; 327(22):1556-63. PubMed ID: 1435882 [TBL] [Abstract][Full Text] [Related]
3. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Aziz TZ; Peggs D; Sambrook MA; Crossman AR Mov Disord; 1991; 6(4):288-92. PubMed ID: 1758446 [TBL] [Abstract][Full Text] [Related]
4. Tissue implants in treatment of parkinsonian syndromes in animals and implications for use of tissue implants in humans. Kopin IJ; Bankiewicz KS; Plunkett RJ; Jacobowitz DM; Oldfield EH Adv Neurol; 1993; 60():707-14. PubMed ID: 8420215 [No Abstract] [Full Text] [Related]
5. [18F]-6-L-fluorodopa PET studies of graft and host dopaminergic function following fetal mesencephalic transplantation. Sawle GV Adv Neurol; 1993; 60():715-20. PubMed ID: 8420216 [No Abstract] [Full Text] [Related]
6. Update on fetal transplantation: the Swedish experience. Lindvall O Mov Disord; 1998; 13 Suppl 1():83-7. PubMed ID: 9613723 [TBL] [Abstract][Full Text] [Related]
7. Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease. Lee CS; Cenci MA; Schulzer M; Björklund A Brain; 2000 Jul; 123 ( Pt 7)():1365-79. PubMed ID: 10869049 [TBL] [Abstract][Full Text] [Related]
8. Embryonic dopamine cell implants as a treatment for the second phase of Parkinson's disease. Replacing failed nerve terminals. Freed CR; Breeze RE; Rosenberg NL; Schneck SA Adv Neurol; 1993; 60():721-8. PubMed ID: 8420217 [No Abstract] [Full Text] [Related]
14. Metabolic energy capacity of dopaminergic grafts and the implanted striatum in parkinsonian nonhuman primates as visualized with cytochrome oxidase histochemistry. Collier TJ; Redmond DE; Roth RH; Elsworth JD; Taylor JR; Sladek JR Cell Transplant; 1997; 6(2):135-40. PubMed ID: 9142445 [TBL] [Abstract][Full Text] [Related]
15. Evidence for target-specific outgrowth from subpopulations of grafted human dopamine neurons. Strömberg I; Törnqvist N; Johansson S; Bygdeman M; Almqvist PM Microsc Res Tech; 2001 Sep; 54(5):287-97. PubMed ID: 11514985 [TBL] [Abstract][Full Text] [Related]
16. Mild parkinsonism in persons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Tetrud JW; Langston JW; Garbe PL; Ruttenber AJ Neurology; 1989 Nov; 39(11):1483-7. PubMed ID: 2812327 [TBL] [Abstract][Full Text] [Related]
17. The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. Histochemical and behavioral studies. Bankiewicz KS; Plunkett RJ; Jacobowitz DM; Porrino L; di Porzio U; London WT; Kopin IJ; Oldfield EH J Neurosurg; 1990 Feb; 72(2):231-44. PubMed ID: 2295921 [TBL] [Abstract][Full Text] [Related]
19. Fetal-tissue transplants in Parkinson's disease. Fahn S N Engl J Med; 1992 Nov; 327(22):1589-90. PubMed ID: 1435887 [No Abstract] [Full Text] [Related]
20. The role of positron emission tomography in the assessment of human neurotransplantation. Sawle GV; Myers R Trends Neurosci; 1993 May; 16(5):172-6. PubMed ID: 7685938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]